10-03-2021, 03:22 AM
"(CNN)Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from Covid-19."
And the Covid management plot thickens. Will be interesting to see what future treatments will surface. Considering there are 75 million people who don't want the shot im thinking that pharma companies will figure out ways to service those folks somehow?!
https://www.google.com/amp/s/amp.cnn.com...index.html
And the Covid management plot thickens. Will be interesting to see what future treatments will surface. Considering there are 75 million people who don't want the shot im thinking that pharma companies will figure out ways to service those folks somehow?!
https://www.google.com/amp/s/amp.cnn.com...index.html